UNSPSC 51431508: Tirofiban hydrochloride anhydrous

This classification denotes an antiplatelet agent with the molecular formula C22H36N2O5S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IKE1P4X57J, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, hydrochloride (1:1), but more generally known as tirofiban hydrochloride anhydrous, which bears US NIH Compound Identifier 64781. European Medicines Agency schedules tirofiban hydrochloride anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11118MIG.

Most nations, for tariff purposes, schedule tirofiban hydrochloride anhydrous under HS 29350090. SMILES: CCCCS(=O)(=O)N[C@@H](CC1CCC(CC1)OCCCCC2CCNCC2)C(=O)O.CL.

UNSPSC 51431508 Tirofiban hydrochloride anhydrous is a Commodity code covering advanced pharmaceutical ingredients and finished medications being solicited by municipal fire and emergency services agencies, state health authorities, and cooperative purchasing alliances for emergency medical use. State and local governments buy under this code when procuring specific pharmaceutical products for emergency medical services operations, health plan pharmacy benefit programs, and institutional medication inventories. The issuing bodies span city fire departments, state health and human services commissions, and multistate cooperative purchasing organizations that aggregate demand across member jurisdictions.

Recent activity shows Tampa Fire Rescue's procurement of advanced life support medications through the City of Tampa's sealed-bid process (Bid No. 26P00188, response deadline April 8, 2026, estimated value $40,000.00), the Texas Health and Human Services Commission's exploratory RFI regarding direct-to-manufacturer pharmacy programs (RFI HHS0017013, posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products distributed through authorized wholesalers to participating state and local government facilities including Oregon (Solicitation S1070000015802, response deadline March 26, 2026). Geographic activity centers on Texas, Minnesota, Florida, and Oregon. The Tampa procurement requires firm pricing including all shipping and applies a 5 percent Small Local Business Enterprise bid discount with a one-year initial term and two one-year renewal options. The Texas RFI is preliminary market research preceding a formal solicitation. The MMCAP cooperative vehicle requires compliance with cGMP, DSCSA, and FDA requirements, maintains two-year contract terms for new vendors with optional extensions, and assesses a 3 percent administrative fee on purchases with performance penalties of $200 to $1,500 per violation for late reporting or missed timelines.